BLRX News and Press, BioLineRx Ltd. From 12/15/21

BioLineRx Announces Formation of Immuno-Oncology Scientific Advisory Board (SAB) SAB will provide insight and guidance on the Company's immuno-oncology activities and is comprised of recognized leaders in the fields of cancer immunology, intra-tumoral injections and clinical dev...

SigmaTron International SGMA +57%. American Virtual Cloud Technologies AVCT +32%. BioLineRx  (NASDAQ:BLRX) +22%. Vasta Platform Limited (NASDAQ:VSTA) +20%. Arhaus ARHS +19%. Everbridge EVBG -46%. AGM Group Holdings  AGMH -38%. Angion Biomedica  ANGN ...

Gainers: American Virtual Cloud Technologies (NASDAQ:AVCT) +50%. Petros Pharmaceuticals (NASDAQ:PTPI) +28%. BioLineRx (NASDAQ:BLRX) +24%. SigmaTron (NASDAQ:SGMA) +20%. Oracle (NYSE:ORCL) +15%. Sprinklr (NYSE:CXM) +15%. Nam Tai Property (NYSE:NTP) +14%. Vasta (NASDAQ:VSTA) +15%. Bottomline Tec...

BioLineRx Ltd. (BLRX) Q3 2021 Earnings Conference Call November 18, 2021, 10:00 AM ET Company Participants Tim McCarthy - LifeSci Advisors, IR Philip Serlin - Chief Executive Officer Mali Zeevi - Chief Financial Officer Ella Sorani - Chief Development Officer Abi Vainstein-Haras - Chief Medic...

biolinerx (NASDAQ:BLRX): Q3 GAAP EPS of -$0.02 beats by $0.11. Cash and cash equivalents at September 30, 2021 of $62.2M Press Release Research and development expenses for the three months ended September 30, 2021 were $4.9M, an increase of $1.4M, or 41.3%, compared to $3.5M for the three mo...

BioLineRx Reports Third Quarter 2021 Financial Results and Provides Corporate Update PR Newswire - Positive results from pharmacoeconomic cost effectiveness study of Motixafortide in stem cell mobilization support its use as standard of care in combin...

biolinerx (NASDAQ:BLRX) is scheduled to announce Q3 earnings results on Wednesday, November 17th, after market close. The consensus EPS Estimate is -$0.13. Over the last 3 months, EPS estimates have seen 0 upward revisions and 1 downward. For further details see: biolinerx Q3 2021 Earni...

ATHM, ATKR, AZEK, BABA, BERY, BJ, BLRX, OTCPK:CNPOF, CSIQ, FINV, HMLP, HP, JD, KNOP, KSS, M, NGG, NJR, PLCE, OTCPK:PSHZF, VIPS, WOOF For Seeking Alpha's full earnings season calendar, click here. For further details see: Notable earnings before Thursday's open

BioLineRx to Report Third Quarter 2021 Results on November 18, 2021 Management to hold a conference call at 10:00 a.m. EST PR Newswire TEL AVIV, Israel , Nov. 12, 2021 /PRNewswire/ -- BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a late clinic...

BioLineRx Announces an Oral Presentation and Three Poster Presentations at the 63rd American Society of Hematology (ASH) Annual Meeting & Exposition BioLineRx Announces an Oral Presentation and Three Poster Presentations at the 63rd American Society of Hematology (ASH) Annua...